معرفی
Magdalena Przybyla is a Research Fellow in the Dementia Research Centre at Macquarie University Medical School. Her work focuses on neurodegenerative diseases, particularly Alzheimer's and frontotemporal dementia, with an emphasis on tau protein mechanisms. She investigates novel treatments using animal models, AAV technology, and molecular biology techniques. Current projects include studying tau propagation in traumatic brain injury and APP's role in tau pathology spread.
- Education: PhD, M.Sc., and B.Sc. from University of Bremen
Research interests span tau protein pathomechanisms, neurodegenerative disease models, and therapeutic interventions. Recent work includes CBD's effects on spatial memory in transgenic mice and SARS-CoV-2-induced neuronal fusion. Key achievements include a 2022 MQRF grant and 13 awards, including the 2021 Biomedical Science Research Award.
Her articles explore topics like neuronal excitotoxicity, TDP-43 pathology, and viral-induced neurodegeneration. She leads projects on tau pathology mechanisms and collaborates internationally on neurodegenerative research.
- Awards: MQRF (2022), DAAD PROMOS (2012), Biomedical Science Award (2021)
- Grants: Active project on APP-tau interactions (2024–2026)
Magdalena is active in editorial roles (e.g., Alzheimer's Research and Therapy) and academic committees. Her lab focuses on translating mechanistic insights into therapies for neurodegenerative diseases.
